Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-eluting bioabsorbable magnesium stent.

Carlo Di Mario1, Huw Griffiths, Omer Goktekin

  • 1Royal Brompton Hospital, London, UK. c.dimario@rbh.nthames.nhs.uk

Journal of Interventional Cardiology
|November 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy.

JACC. Cardiovascular interventions·2019
Same author

The SYNTAX score on its way out or … towards artificial intelligence: part II.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2019
Same author

The SYNTAX score on its way out or … towards artificial intelligence: part I.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2019
Same author

Prognostic relevance of GRACE risk score in Takotsubo syndrome.

European heart journal. Acute cardiovascular care·2019
Same author

Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study.

Lancet (London, England)·2019
Same author

Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses: The Disrupt CAD II Study.

Circulation. Cardiovascular interventions·2019

This study introduces the first biodegradable magnesium alloy stent, offering potential benefits over permanent implants. Clinical results will determine if it prevents restenosis without traditional drugs.

Area of Science:

  • Biomaterials Science
  • Cardiovascular Engineering
  • Medical Device Innovation

Background:

  • Permanent metallic stents can cause long-term vascular issues, including stiffness and inability to adapt to vessel changes.
  • Current stent technology often requires antiproliferative drugs to prevent restenosis, leading to "full metal jackets" in coronary vessels.
  • The limitations of permanent stents necessitate the development of alternative, adaptive solutions for vascular repair.

Purpose of the Study:

  • To introduce and evaluate the first biodegradable stent engineered from a magnesium alloy.
  • To assess the safety and efficacy of magnesium-based biodegradable stents in preclinical and early clinical settings.
  • To investigate the potential of magnesium's inherent therapeutic properties (antithrombotic, antiarrhythmic, antiproliferative) as an alternative to drug-eluting stents.

Related Experiment Videos

Main Methods:

  • Development of a biodegradable stent utilizing a magnesium alloy with controlled corrosion properties.
  • Preclinical evaluation through animal experiments to assess stent performance and biological response.
  • Initial clinical application in 20 patients with below-the-knee implants, with ongoing data collection.

Main Results:

  • The biodegradable magnesium alloy stent demonstrates controlled corrosion and release of magnesium, a natural body component.
  • Animal studies indicated promising antithrombotic, antiarrhythmic, and antiproliferative effects.
  • Early clinical data from below-the-knee applications are pending final results, with plans for coronary studies.

Conclusions:

  • Biodegradable magnesium alloy stents represent a novel approach to vascular repair, potentially overcoming limitations of permanent implants.
  • The study's findings will elucidate whether magnesium's inherent properties are sufficient to prevent restenosis or if modification with antiproliferative drugs is necessary.
  • Further clinical investigation is crucial to establish the efficacy of biodegradable stents in preventing restenosis in humans.